ML-246 (metarrestin) stability studies

Ended Awarded Last action

Contract number
75N95022F00001
Awardee
Awarding agency
Obligated
$131,900

Award facts

Contract value 100% obligated
$131,900.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Kansas City, MO 64110, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Change Order P00002 $39,295
Supplemental Agreement for work within scope P00001 $36,173
Original award $56,432

About this award

The National Institute on Drug Abuse issued a $131,900 delivery order to Mriglobal (doing business as Midwest Research Institute) on June 3, 2022, under the CRO Support for NCATS Drug Substance Development and Manufacture contract for stability studies on ML-246 (METARRESTIN) and contract research organization support for drug substance development and manufacture.

Place of performance is Kansas City, MO. The order is firm fixed price with an ultimate completion date of January 30, 2028. No set-aside was used.

Quick answers

Who was awarded contract 75N95022F00001?

75N95022F00001 was awarded to Mriglobal by National Institute on Drug Abuse (National Institutes of Health) on June 3, 2022.

How much is contract 75N95022F00001 worth?

The government has obligated $131,900 on 75N95022F00001.

Is contract 75N95022F00001 an order under another contract?

Yes. 75N95022F00001 is a delivery order under HHSN271201700006I, an indefinite delivery contract, on CRO Support for NCATS Drug Substance Development and Manufacture.

Was contract 75N95022F00001 competed?

The extent of competition for 75N95022F00001 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award